Intellia Therapeutics Inc (NTLA)
20.36
+0.34
(+1.67%)
USD |
NASDAQ |
Apr 26, 11:11
Intellia Therapeutics Accounts Receivable (Quarterly): 36.46M for Dec. 31, 2023
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 36.46M |
September 30, 2023 | 6.491M |
June 30, 2023 | 5.056M |
March 31, 2023 | 4.906M |
December 31, 2022 | 3.768M |
September 30, 2022 | 4.023M |
June 30, 2022 | 2.854M |
March 31, 2022 | 1.801M |
December 31, 2021 | 2.031M |
September 30, 2021 | 2.491M |
June 30, 2021 | 1.993M |
March 31, 2021 | 0.953M |
December 31, 2020 | 2.13M |
September 30, 2020 | 1.217M |
June 30, 2020 | 3.864M |
March 31, 2020 | 13.37M |
December 31, 2019 | 4.62M |
Date | Value |
---|---|
September 30, 2019 | 3.599M |
June 30, 2019 | 4.188M |
March 31, 2019 | 3.591M |
December 31, 2018 | 7.547M |
September 30, 2018 | 2.813M |
June 30, 2018 | 8.609M |
March 31, 2018 | 7.466M |
December 31, 2017 | 10.47M |
September 30, 2017 | 4.493M |
June 30, 2017 | 2.764M |
March 31, 2017 | 2.443M |
December 31, 2016 | 6.454M |
September 30, 2016 | 1.112M |
June 30, 2016 | 1.00M |
March 31, 2016 | 1.00M |
December 31, 2015 | 1.00M |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
0.953M
Minimum
Mar 2021
36.46M
Maximum
Dec 2023
5.569M
Average
3.768M
Median
Dec 2022
Accounts Receivable (Quarterly) Benchmarks
Moderna Inc | 892.00M |
Regeneron Pharmaceuticals Inc | 5.667B |
NeuroMetrix Inc | 0.5188M |
Repligen Corp | 124.16M |
Pacific Biosciences of California Inc | 36.62M |